Jazz

Business

Jazz Pharma PTSD mid-stage trial fails to meet main goal (NASDAQ:JAZZ)

AndreyPopov Jazz Pharmaceuticals (NASDAQ:JAZZ) on Thursday said a mid-stage trial of its investigational therapy for the treatment of post-traumatic stress…

Read More »
Back to top button